UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G

 

Amendment No. 3

 

Under the Securities and Exchange Act of 1934

 

Zivo Bioscience, Inc.

(Name of Issuer)

 

Common Stock, $.001 par value

(Title of Class of Securities)

 

98978N 101

(CUSIP Number)

 

September 7, 2017

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this is filed:

 

[   ] Rule 13d-1(b)

 

[X] Rule 13d-1(c)

 

[   ] Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


1


CUSIP NO. 98978N 101

 

Page 2 of 4 Pages

 

 

 

1

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (entities only)

 

Christopher D. Maggiore

 

 

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

 

(a) [   ]

(b) [   ]

 

 

3

SEC USE ONLY

 

 

 

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

U.S.A.

 

 

 

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 

 

 

5

 

 

SOLE VOTING POWER

 

25,444,232 shares

 

6

 

SHARED VOTING POWER

 

7,586,622 shares

 

 

7

SOLE DISPOSITIVE POWER

 

25,444,232 shares

 

 

8

SHARED DISPOSITIVE POWER

 

7,586,622 shares

 

9

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

33,030,854

 

 

10

CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

 

N/A

 

11

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

21.7%

 

 

12

TYPE OF REPORTING PERSON

 

IN


2


Item 1(a)

 

The name of the issuer is Zivo Bioscience, Inc.

 

Item 1(b)

 

The address of the Issuer's principal executive offices is: 2804 Orchard Lake Rd., Keego Harbor, Michigan 48320

 

Tel. Number: (248) 452 9866

 

Item 2(a)

 

The name of reporting person is: Christopher D. Maggiore

 

Item 2(b)

 

The residence address of the Reporting Person is: 4788 Nobles Pond Dr. NW, Canton, OH 44718

 

Item 2(c)

 

The citizenship of the reporting Person is: USA

 

Item 2(d)

 

The title of the class of securities is: Common Stock, $0.001 par value

 

Item 2(e)

 

The CUSIP Number of the securities is: 98978N 101

 

Item 3

 

This statement is not filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c).

 

Item 4

 

Ownership:

 

The Reporting Person is the beneficial owner of 33,030,854 shares, representing 21.7% of the

class of securities.

 

The Reporting Person has:

 

(i)sole power to vote or to direct the vote of: 25,444,232 shares 

(ii)shared power to vote or to direct the vote of: 7,586,622 shares 

(iii)sole power to dispose or to direct the disposition of: 25,444,232 shares 

(iv)shared power to dispose or to direct the disposition of: 7,586,622 shares 

 

Item 5

 

Ownership of Five Percent or Less of Class: Not Applicable

 

Item 6

 

Ownership of More than Five Percent on Behalf of another Person: Not Applicable


3


Item 7

 

Identification and Classification of the Subsidiary which Acquired the Security Being Reported on By the Parent Holding Company: Not Applicable

 

Item 8

 

Identification and Classification of Members of the Group: Not Applicable

 

Item 9

 

Notice of Dissolution of Group: Not Applicable

 

Item 10

 

Certification:

 

By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

September 13, 2017

Date

 

/s/ Christopher D. Maggiore

Signature

 

Christopher D. Maggiore

Name


4